 |
Journal articles
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
P. Saiag
1, *
R. Gutzmer
2
P. A. Ascierto
3
M. Maio
4
J.-J. Grob
5
P. Murawa
6
Brigitte Dréno
7, 8
M. Ross
9
J. Weber
10
A. Hauschild
11
P. Rutkowski
12
A. Testori
13
E. Levchenko
14
A Enk
15
Laurent Misery
16
C. Vanden Abeele
17
I. Vojtek
17
O. Peeters
17
V. Brichard
17
P. Therasse
17
*
Corresponding author
1
Service de Dermatologie Générale et Oncologique [AP-HP Hôpital Ambroise-Paré, Paris] (9 Avenue Charles de Gaulle, 92100 Boulogne-Billancourt - France)
- Hôpital Ambroise Paré [AP-HP] (9, avenue Charles de Gaulle92104 Boulogne-Billancourt cedex - France)
2
Skin Cancer Center Hannover (Germany)
- MHH - Hannover Medical School [Hannover] (Medizinische Hochschule Hannover Carl-Neuberg-Str. 1 30625 Hannover Telefon: (0511) 532-0 Phone: +49 511 532-0 - Germany)
3
National Institute for Tumors Foundation (Italy)
4
Medical Oncology and Immunotherapy (Siena, Italy - Italy)
- Istituto Toscano Tumori (France)
- Department. of Oncology (France)
- Hospital of Siena (France)
5
TIMONE - Hôpital de la Timone [CHU - APHM] (France)
6
Poznań University of Medical Sciences (Poland)
- Poznan University of Medical Sciences (Collegium Maius, Fredry 10, 61-701 Poznań - Poland)
7
Service de dermatologie [Nantes] (France)
- UN - Université de Nantes (1, quai de Tourville - BP 13522 - 44035 Nantes cedex 1 - France)
- CHU Nantes - Centre hospitalier universitaire de Nantes (1 Place Alexis-Ricordeau, 44000 Nantes - France)
8
CRCNA - Centre de Recherche en Cancérologie Nantes-Angers (France)
- CHU Angers - Centre Hospitalier Universitaire d'Angers (4 rue Larrey - 49933 Angers cedex 9 - France)
- Hôtel-Dieu de Nantes (France)
- INSERM - Institut National de la Santé et de la Recherche Médicale (101, rue de Tolbiac, 75013 Paris - France)
- Hôpital Laennec (France)
- CNRS - Centre National de la Recherche Scientifique (France)
- Faculté de Médecine d'Angers (Rue Haute de Reculée 49045 Angers - France)
- CHU Nantes - Centre hospitalier universitaire de Nantes (1 Place Alexis-Ricordeau, 44000 Nantes - France)
9
MD Anderson Cancer Center [Houston] (1515 Holcombe Blvd, Houston, TX 77030 - United States)
- UTHealth - The University of Texas Health Science Center at Houston (7000 Fannin, Suite 1200 Houston, Texas 77030 - United States)
10
H. Lee Moffitt Cancer Center & Research Institute (Denmark)
11
University of Kiel, UKSH (France)
14
Petrov Research Insitut of Oncology (68 Leningradskaya Street
Pesochny
197758
St Petersburg - Russia)
15
Heidelberg University (Seminarstraße 2, 69117 Heidelberg - Germany)
16
Dermato - BREST - Service de dermatologie (Hôpital Augustin Morvan Brest, France - France)
17
GSK Vaccines - Belgium (France)
Abstract : .
Document type :
Journal articles
Domain :
Complete list of metadata
https://www.hal.inserm.fr/inserm-01407384
Contributor : Elizabeth Bernardo <>
Submitted on : Friday, December 2, 2016 - 9:09:04 AM
Last modification on : Wednesday, March 24, 2021 - 2:24:02 PM
Long-term archiving on: : Thursday, March 23, 2017 - 12:01:26 AM
Contributor : Elizabeth Bernardo <>
Submitted on : Friday, December 2, 2016 - 9:09:04 AM
Last modification on : Wednesday, March 24, 2021 - 2:24:02 PM
Long-term archiving on: : Thursday, March 23, 2017 - 12:01:26 AM
File
AnnOncol2016Eq2.pdf
Files produced by the author(s)
Identifiers
- HAL Id : inserm-01407384, version 1
- DOI : 10.1093/annonc/mdw291
Collections
INSERM | CNRS | UNIV-NANTES | UNAM | POLITIQUES-PUBLIQUES
Citation
P. Saiag, R. Gutzmer, P. A. Ascierto, M. Maio, J.-J. Grob, et al.. Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). Annals of Oncology, Elsevier, 2016, 27, pp.1947 - 1953. ⟨10.1093/annonc/mdw291⟩. ⟨inserm-01407384⟩
Metrics
Record views
227
Files downloads